Tag Archives: Tracleer

FDA chief Gottlieb makes good on promise to increase drug price competition; will expedite review of generics

The Food and Drug Administration on Tuesday (June 27, 2017) moved to try to spur more competition in the market for generic drugs, an effort aimed at driving down prices. In… Read more »

IPO Alert: Actelion founders launch startup on $1.5 billion J&J payday: call your broker, soon

Steve’s Take: If ever there was a “story” biotech IPO worth grabbing even a tiny piece of, this is it. First, the story: Two decades ago Jean-Paul and Martine Clozel… Read more »

J&J finally captures Actelion for $30 billion; deal looks good for both unless “what ifs” bite pharma giant’s shareholders

The News: It took months but Swiss biotech Actelion Ltd. (Allschwil) said on Thursday (January 26, 2017) it had agreed to be purchased by Johnson & Johnson (New Brunswick NJ) in a… Read more »

Johnson & Johnson eyeing Actelion; who wouldn’t with a “pro-biotech” Trump administration?

Johnson & Johnson (New Brunswick NJ) said Friday (November 11, 2016) it is in “preliminary discussions” with Swiss drug company Actelion Pharmaceuticals Ltd. (Basel CHE), a deal that would help the… Read more »